MALARIA (PLASMODIUM FALCIPARUM)
Clinical trials for MALARIA (PLASMODIUM FALCIPARUM) explained in plain language.
Never miss a new study
Get alerted when new MALARIA (PLASMODIUM FALCIPARUM) trials appear
Sign up with your email to follow new studies for MALARIA (PLASMODIUM FALCIPARUM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Liver-Stage malaria vaccine shield mothers and babies?
⭐️ VACCINE ⭐️ Not yet recruitingThis phase 2 trial tests a new malaria vaccine (PfSPZ-LARC2) designed to stop the malaria parasite in the liver before it can cause illness. The study involves 300 healthy women of childbearing age in Mali who plan to become pregnant. Participants receive three doses of the vacci…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE2 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 02, 2026 00:00 UTC
-
Smart wristbands may spot malaria before symptoms strike
Diagnosis Not yet recruitingThis early-stage study tests whether wearable biosensors (like a wristband or earphones) can detect malaria infection before symptoms appear. 32 healthy adults will be exposed to the malaria parasite or a placebo in a controlled setting. Researchers will compare biosensor reading…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated Jun 27, 2026 12:27 UTC
-
One shot to stop malaria? new injection tested in rwanda
Prevention Not yet recruitingThis study tests a new long-acting injection called MMV371 to see if it is safe and can prevent malaria. About 80 healthy people aged 12 to 50 in Rwanda will get either the study drug or a placebo. Researchers will check if the injection protects against malaria and monitor side …
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC